Table 1 Patients baseline characteristics
Male | Female | |||||||
Number of patients | 14 | 22 | ||||||
Enzyme activity (Agal U)a | 3.9 | ± | 1.2 | 15.2 | ± | 6.6 | ||
Onset (y.o.)a | 7.7 | ± | 7.7 | 13.5 | ± | 10.7 | ||
Age (y.o.)a | 26.6 | ± | 10.4 | 45.4 | ± | 16.4 | ||
N | ( | % | ) | N | ( | % | ) | |
Pain attack | 11 | ( | 78.6 | ) | 6 | ( | 27.3 | ) |
Angiokeratoma | 7 | ( | 50 | ) | 4 | ( | 18.2 | ) |
Hypohidrosis | 10 | ( | 71.4 | ) | 4 | ( | 18.2 | ) |
Depression | 1 | ( | 7.1 | ) | 3 | ( | 13.6 | ) |
Stroke | 2 | ( | 14.3 | ) | 2 | ( | 9.1 | ) |
Corneal opacity | 10 | ( | 71.4 | ) | 16 | ( | 72.7 | ) |
Tinnitus | 6 | ( | 42.9 | ) | 4 | ( | 18.2 | ) |
Dizziness | 0 | ( | 0 | ) | 5 | ( | 22.7 | ) |
Diarrhea | 7 | ( | 50 | ) | 8 | ( | 36.4 | ) |
Hypertension | 1 | ( | 7.1 | ) | 1 | ( | 4.5 | ) |
Angina | 3 | ( | 21.4 | ) | 3 | ( | 13.6 | ) |
LVHb | 1 | ( | 7.1 | ) | 9 | ( | 40.9 | ) |
Proteinuria | 5 | ( | 35.7 | ) | 4 | ( | 18.2 | ) |
Renal failure | 0 | ( | 0 | ) | 2 | ( | 9.1 | ) |